Latest news articles

Added 1 day ago Drug news

Analysis of phase III TWILIGHT trial for Brilinta showed reduced risk of bleeding in acute coronary syndromes.- AstraZeneca

New results from a pre-specified subgroup analysis of the TWILIGHT trial showed that Brilinta (ticagrelor) monotherapy, from AstraZeneca, reduced the...

Added 2 days ago Drug news

FOURIER outcomes phase III study of Repatha shows effectiveness in myocardial infarction.- Amgen

Amgen announced a new analysis from the Repatha (evolocumab) cardiovascular outcomes (FOURIER) phase III study that evaluates the effectiveness of...

Added 1 month ago Drug news

Successful results from EVOLVE Short DAPT clinical trial shows low rates of adverse events- Boston Scientific

Boston Scientific has announced primary endpoint results from the EVOLVE Short DAPT clinical trial, the first prospective study initiated in...

Search all news articles for Coronary atherosclerosis
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Anticoagulation Therapy for Stroke Prevention

Anticoagulation Therapy for Stroke Prevention

Anticoagulation therapy for Stroke Prevention Learning Zone offers a deep-dive into atrial fibrillation causes, consequences, diagnosis and management to help you deliver optimal care and prevent strokes in patients living with this common arrhythmia.

ESICM LIVES Highlights

ESICM LIVES Highlights

ESICM LIVES Congress 2018: Bringing you the latest news and insights from the 31st ESICM LIVES Congress, 20–24 October 2018 Paris, France.

Load more

Guidelines

Cardiac arrhythmias in coronary heart disease

This guideline provides evidence-based recommendations for the management of cardiac arrest and the arrhythmias associated with ACS, chronic CHD and cardiac surgery. It excludes arrhythmias not associated with CHD such as...

Added 2 months ago

2018 ESC/EACTS Guidelines on myocardial revascularization

These Guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body of evidence, with the mission of drafting balanced...

Added 5 years ago

Cardiac rehabilitation

This guideline provides evidence-based recommendations and best practice guidance on the management of patients referred for cardiac rehabilitation. It provides recommendations on assessment, health behaviour-change techniques...

Added 2 months ago

Search all guidelines for Coronary atherosclerosis
 

Journal articles

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

Objective: To study the safety and efficacy of different antithrombotic regimens using a network meta-analysis of randomized controlled trials in this population.

Added 2 months ago

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Background: Appropriate antithrombotic regimens for patients with atrial fibrillation who have an acute coronary syndrome or have undergone percutaneous coronary intervention (PCI) are unclear.

Added 2 months ago

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.

Aims: After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of patients undergoing PCI due to acute coronary...

Added 2 months ago

Search all journal articles for Coronary atherosclerosis
 

Clinical trials

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...

Added 7 years ago

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients...

Added 2 years ago

Testosterone Replacement in Older Men and Atherosclerosis Progression

As men grow older, their testosterone levels decrease with age.

Added 2 years ago

Search all clinical trials for Coronary atherosclerosis
 
My Urology Doc

I am a general urologist and men's health expert in Indianapolis, Indiana, U.S.A. I'm also an avid blogger and heath innovator. My social media brand, My Urology Doc, aims to make the formerly taboo world of urology more fun and appealing.

Men's Health: A Forgotten Topic

Men's health is a forgotten topic. To be honest, we men are mostly to blame. We've clung to our masculine misconceptions and repeatedly refused to engage the healthcare community. Who can blame us, we're invincible and we're going to live forever, right? Well, not exactly. Let's look at some of the reasons men's health is one of the least engaged topics in healthcare. 

CME

Anticoagulation

Accrediting body
BJC Learning
Credits available
5
Registration required
1
Subscription fee
0

Stable angina

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
5

Cardiac rehabilitation

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Coronary atherosclerosis